- Home
- SKX vs BMRN Comparison
SKX vs BMRN Comparison
Compare SKX & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKX
- BMRN
- Stock Information
- Founded
- SKX 1992
- BMRN 1996
- Country
- SKX United States
- BMRN United States
- Employees
- SKX N/A
- BMRN N/A
- Industry
- SKX Shoe Manufacturing
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- SKX Consumer Discretionary
- BMRN Health Care
- Exchange
- SKX Nasdaq
- BMRN Nasdaq
- Market Cap
- SKX 9.5B
- BMRN 11.3B
- IPO Year
- SKX 1999
- BMRN 1999
- Fundamental
- Price
- SKX $63.20
- BMRN $57.77
- Analyst Decision
- SKX Buy
- BMRN Buy
- Analyst Count
- SKX 13
- BMRN 23
- Target Price
- SKX $68.67
- BMRN $93.14
- AVG Volume (30 Days)
- SKX 2.8M
- BMRN 1.8M
- Earning Date
- SKX 10-23-2025
- BMRN 10-28-2025
- Dividend Yield
- SKX N/A
- BMRN N/A
- EPS Growth
- SKX 17.44
- BMRN 154.69
- EPS
- SKX 4.38
- BMRN 3.40
- Revenue
- SKX $9,411,716,000.00
- BMRN $3,063,608,000.00
- Revenue This Year
- SKX $8.68
- BMRN $13.32
- Revenue Next Year
- SKX $7.28
- BMRN $9.37
- P/E Ratio
- SKX $14.45
- BMRN $16.97
- Revenue Growth
- SKX 12.11
- BMRN 18.36
- 52 Week Low
- SKX $44.50
- BMRN $52.93
- 52 Week High
- SKX $78.85
- BMRN $90.01
- Technical
- Relative Strength Index (RSI)
- SKX 61.77
- BMRN 48.39
- Support Level
- SKX $63.12
- BMRN $55.99
- Resistance Level
- SKX $63.25
- BMRN $59.79
- Average True Range (ATR)
- SKX 0.10
- BMRN 1.37
- MACD
- SKX 0.01
- BMRN -0.05
- Stochastic Oscillator
- SKX 86.11
- BMRN 46.84
About SKX Skechers U.S.A. Inc.
Skechers USA Inc is a lifestyle footwear company under the Skechers GO brand name. Products offered include various styles of women's shoes, men's shoes, girl's shoes, boy's shoes, performance shoes, and work shoes. Allied products offered are apparel, bags, eyewear, toys, and more. Its products are available for sale at department and specialty stores, athletic and independent retailers, boutiques, and internet retailers. The company's operating segments includes Wholesale and Direct-to-Consumer. It generates maximum revenue from the Wholesale segment.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.